In this talk, we explore some of the challenges and opportunities inherent to the adoption of remote monitoring, AI and wearables. We draw on our experience to demonstrate how the digital transformation of trials is possible with a collaborative approach between engineering, healthcare bodies and the pharmaceutical industry.
The future of patient monitoring
Within months, thanks to the Internet of Things, we will have an estimated 646 million connected medical devices generating healthcare data and sending it to the cloud along with rich, contextual mobile human data from wearables. When setting up new clinical trials, we have the opportunity to combine all this data with advanced AI tools to help us design better trials. This will give us better understanding of outcomes and maximize the likelihood of clinical and commercial success.